In the Young Pearl study, low interferon and high T-reg expression also showed a trend toward a worse prognosis after palbociclib and ET.
← all excerpts
Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration.
1
—
—